I wonder if i have
a patient after myocardial infarction, high levels of inflammatory markers, when is it safe to give him PUFAs?
Ischemic mitral regurgitation of moderate severity develops in approximately 10 percent of
patients after myocardial infarction.
Not exact matches
OBTAIN (Outcomes of Beta - Blocker Therapy
After Myocardial Infarction) is an observational multicenter registry in which beta - blocker dosing information was collected in
patients with an acute heart attack at participating centers to assess the effect of dose on survival.
Three of the
patients did not complete chemotherapy — one died
after consent but prior to chemotherapy; one died during chemotherapy because of an arterial occlusion; and one had a
myocardial infarction prior to completion of the four courses of chemotherapy.
Among these studies are studies on more than 19,000 children representing of 47,000
patient years of growth hormone treatment; a prospective study of 100 adult growth hormone — deficient
patients followed for 1 to 4 years, a study of 910 children treated with growth hormone for 11 years, a study of 32 adults and children followed for up to 40 years treated with growth hormone (average 10.8 years); a study of 180 growth hormone — treated children followed for over 6 years with reduced cancer recurrence risk (RR 0.6); a prospective analysis of 289 growth hormone — deficient adults who,
after 5 years of growth hormone therapy, showed lower risk of malignancy (RR 0.25) and decreased risk of
myocardial infarction (RR 0.19) and early mortality (RR 0.22) compared with the untreated group.
RESULTS: A total of 36,354
patients (33.9 %) claimed at least 1 prescription of an NSAID
after discharge; 60,974 (56.9 %) died, and 8970 (8.4 %) and 39,984 (37.5 %) were hospitalized with
myocardial infarction or HF, respectively.
Factors influencing female
patients» recovery
after their first
myocardial infarction as experienced by cardiac rehabilitation nurses